Home
/
Treatment
/
(1’R,6’R)-3-(benzylamine)-6-hydroxy-3′-methyl-4-pentyl-6′-(prop-1-en-2-yl)-[1,1′-bi(cyclohexane)]-2′,3,6-triene-2,5-dione

(1’R,6’R)-3-(benzylamine)-6-hydroxy-3′-methyl-4-pentyl-6′-(prop-1-en-2-yl)-[1,1′-bi(cyclohexane)]-2′,3,6-triene-2,5-dione

	(1’R,6’R)-3-(benzylamine)-6-hydroxy-3′-methyl-4-pentyl-6′-(prop-1-en-2-yl)-[1,1′-bi(cyclohexane)]-2′,3,6-triene-2,5-dione
Trade Name
Orphan Indication	Systemic scleroderma
EU Market Approval	EU
EU Designation Date	2017-11-08 00:00:00
Sponsor	Quintiles Ireland Limited